#2 - Antibodies drive irreproducibility (On-Demand)
Professor Glenn Begley, Biocurate Pty Ltd, and Professor Cecilia Williams, KTH Royal Institute of Technology, describe arduous, alarming and very costly experiences in failing to confirm “well established” critical data in oncology –a failure often driven by ineptly characterized antibodies.
Seminar Date:
November 13, 2019